参芪健心方抑制内质网应激改善心力衰竭大鼠心功能OA
Shenqi Jianxin Formula Improves Cardiac Function in Heart Failure Rats by Inhibiting Endoplasmic Reticulum Stress
目的 观察参芪健心方改善心力衰竭(HF)的作用,并探讨其通过调节唾液酸转移酶7A(Siat7A)与内质网分子伴侣蛋白葡萄糖调节蛋白78(GRP78)的表达减轻内质网应激(ERS)的作用机制.方法 将采用腹主动脉缩窄术成功构建的HF模型大鼠24只随机分为模型组、参芪健心方高、低剂量组[17.64、4.41 g/(kg·d)]及沙库巴曲缬沙坦钠组[10 mg/(kg·d)],每组6只,另取6只大鼠作为假手术组,仅分离血管不缩窄.干预组给予相应药物灌胃,干预4周.超声心动图评估心功能;ELISA检测大鼠血清心房利钠肽(ANP)、B型钠尿肽(BNP)水平;HE/Masson染色观察心肌病理变化;RT-qPCR、Western Blot及免疫组化检测Siat7A、GRP78 mRNA及蛋白表达.结果 模型组大鼠摄食量及排尿量下降,被毛泛黄且干枯,活动意愿减弱,HE及Masson染色显示心肌纤维排列紊乱、断裂;各干预组上述病理状态不同程度改善.与假手术组比较,模型组左室射血分数(LVEF)、左心室短轴缩短率(LVFS)降低,血清ANP、BNP水平、心肌组织Siat7A、GRP78 mRNA及蛋白表达上升(P<0.05).干预组上述指标较模型组改善(P<0.05),参芪健心方高剂量组及沙库巴曲缬沙坦钠组改善较参芪健心方低剂量组更为明显(P<0.05).结论 参芪健心方可改善HF大鼠心室结构与心功能,降低血清心衰标志物水平,减轻心肌纤维化程度.其作用机制或与调节Siat7A及GRP78并抑制ERS有关.
Objective To evaluate the therapeutic efficacy of Shenqi Jianxin Formula(SQJXF)in heart failure(HF)and to investigate whether its cardioprotective effects involve modulation of sialyltransferase 7A(Siat7A)and the endoplasmic reticulum(ER)chaperone glucose-regulated protein 78(GRP78),thereby attenuating endoplasmic reticulum stress(ERS).Methods A rat model of HF was established via abdominal aortic constriction.Twenty-four successfully modeled rats were randomly divided to four groups(6 rats in each group):HF model,SQJXF high-dose and low-dose groups(17.64,4.41 g·kg-1·d-1),and sacubitril/valsartan sodium group(10 mg·kg-1·d-1).An additional six rats underwent sham surgery without vascular constriction.All interventions were administered by oral gavage for 4 weeks.Cardiac function was assessed by echocardiography.Serum levels of atrial natriuretic peptide(ANP)and B-type natriuretic peptide(BNP)were quantified using ELISA.Histopathological alterations and myocardial fibrosis were evaluated by hematoxylin-eosin(HE)and Masson's trichrome staining.Expression levels of Siat7A and GRP78 mRNA and protein were determined using RT-qPCR,Western Blot,and immunohistochemistry.Results HF model rats exhibited reduced food intake and urine output,dull and coarse fur,and decreased activity.HE and Masson staining revealed disorganized and disrupted myocardial fibers.These pathological features were ameliorated to varying degrees following intervention.Compared with the sham group,HF rats showed significantly reduced left ventricular ejection fraction(LVEF)and fractional shortening(LVFS),alongside elevated serum ANP and BNP levels and increased myocardial expression of Siat7A and GRP78 mRNA and protein(P<0.05).All intervention groups demonstrated significant improvements in these parameters relative to the model group(P<0.05).The SQJXF high-dose and sacubitril/valsartan groups exhibited more pronounced effects than the SQJXF low-dose group(P<0.05).Conclusions SQJXF significantly improves ventricular structure and cardiac function in HF rats,reduces circulating biomarkers of heart failure,and attenuates myocardial fibrosis.These effects are likely mediated through regulation of Siat7A and GRP78 expression and subsequent suppression of ER stress.
丁子彤;刘攀;谢沛池;白敬一;庞德棋;戴小华
安徽中医药大学第一临床医学院(合肥 230022)安徽中医药大学中医学院(合肥 230012)安徽中医药大学第一临床医学院(合肥 230022)安徽中医药大学第一临床医学院(合肥 230022)安徽中医药大学第一临床医学院(合肥 230022)安徽中医药大学第一附属医院心血管内科(合肥 230031)
心力衰竭参芪健心方Siat7A/GRP78蛋白内质网应激心室重构中药复方
heart failureShenqi Jianxin FormulaSiat7A/GRP78 proteinsendoplasmic reticulum stressmyocardial remodelingChinese herbal compound
《中国中西医结合杂志》 2026 (8)
938-945,8
安徽中医药大学校级探索性科研项目(No.AHUCM2024TS085)
评论